Perfil
Gary Acton worked as a Managing Director for the European Region at CTI BioPharma Corp.
He was a Non-Executive Director at Neuropharm Group Plc from 2007 to 2010.
He also worked as a Vice President for Clinical Development at Ligand UK Ltd.
and as a Chief Medical Officer at Sarossa Capital Ltd.
Antiguos cargos conocidos de Gary Acton.
Empresas | Cargo | Fin |
---|---|---|
Neuropharm Group Plc
Neuropharm Group Plc Pharmaceuticals: MajorHealth Technology Neuropharm Group Plc develops and manufactures speciality pharmaceuticals. It develops medicines for the treatment and management of neurodevelopmental disorders. The company was founded by Dr. Michael Snape and is headquartered in Leatherhead, the United Kingdom. | Director/Miembro de la Junta | 12/07/2010 |
CTI BIOPHARMA CORP. | Corporate Officer/Principal | - |
VERNALIS | Director Técnico/Científico/I+D | - |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Director Técnico/Científico/I+D | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 4 |
---|---|
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
Ligand UK Ltd.
Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
Neuropharm Group Plc
Neuropharm Group Plc Pharmaceuticals: MajorHealth Technology Neuropharm Group Plc develops and manufactures speciality pharmaceuticals. It develops medicines for the treatment and management of neurodevelopmental disorders. The company was founded by Dr. Michael Snape and is headquartered in Leatherhead, the United Kingdom. | Health Technology |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Finance |
- Bolsa de valores
- Insiders
- Gary Acton